Article
How do aminoadamantanes block the influenza M2 channel, and how does resistance develop?
Journal of the American Chemical Society - 29 Jun 2011
Leonov Hadas, Astrahan Peleg, Krugliak Miriam, Arkin Isaiah T
Abstract excerpt
The interactions between channels and their cognate blockers are at the heart of numerous biomedical phenomena. Herein, we unravel one particularly important example bearing direct pharmaceutical relevance: the blockage mechanism of the influenza M2 channel by the anti-flu amino-adamantyls (amantadine and rimantadine) and how the channel and, consequently, the virus develop resistance against them. Using both...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
